Ironwood Pharmaceuticals, Inc. (IRWD) Live Share Price, Invest From India

Ironwood Pharmaceuticals, Inc. Stock Performance

as on October 18, 2025 at 1:29 am IST

Day's Low
Day's High
$1.43
Day's Price Range
$1.57
$1.44
0.69%
Downside
9.03%
Upside
52 Week's Low
52 Week's High
$0.53
52-Week Price Range
$5.13
$1.44
63.40%
Downside
256.17%
Upside

Ironwood Pharmaceuticals, Inc. share price movements today

Previous Close: $1.55
Open: $1.55
Volume: 1.4M
Day's Low - High: $1.43 - $1.57
52 Week Low - High: $0.53 - $5.13

Ironwood Pharmaceuticals, Inc. Historical Returns

1 Month Return: + 21.09 %
3 Month Return: + 96 %
1 Year Return: -65.09 %
3 Year Return: -84.82 %
5 Year Return: -85.05 %

Ironwood Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Check Ironwood Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$261.5M

EPS (TTM)

0.21

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.77%

PE Ratio (TTM)

88.61

Industry PE ratio

-0.32286624203821657

PEG Ratio

-0.26

EBITDA

93.7M

Revenue (TTM)

308.5M

Profit Margin

-2.56%

Return On Equity TTM

4195600.00%

Ironwood Pharmaceuticals, Inc. Stock Valuation

Track how Ironwood Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.

Ironwood Pharmaceuticals, Inc. in the last 5 years

Overview
Trends

Lowest (-22.60x)

March 31, 2025

Industry (-0.32x)

October 17, 2025

Today (88.61x)

October 17, 2025

Highest (129.55x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 88.61x

Ironwood Pharmaceuticals, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ironwood Pharmaceuticals, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Ironwood Pharmaceuticals, Inc.	BUY	$261.5M	-85.05%	88.61	-2.56%
United Therapeutics Corporation	BUY	$19.6B	NA	16.88	40.36%
Haleon Plc Spon Ads	BUY	$40.9B	NA	20.42	13.81%
Neurocrine Biosciences Inc.	BUY	$13.6B	34.15%	40.81	13.88%
Zoetis Inc.	BUY	$63.5B	-12.41%	24.66	27.83%

Stock Returns calculator for Ironwood Pharmaceuticals, Inc. Stock including INR - Dollar returns

The Ironwood Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Ironwood Pharmaceuticals, Inc. investment value today

Current value as on today

₹37,346

Returns

₹62,654

(-62.65%)

Returns from Ironwood Pharmaceuticals, Inc. Stock

₹67,568 (-67.57%)

Dollar Returns*

₹4,914 (+4.91%)

Analyst Recommendation on Ironwood Pharmaceuticals, Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Ironwood Pharmaceuticals, Inc.. Average target price of $0.95

Ironwood Pharmaceuticals, Inc. Share Price Target

Get share price movements and forecasts by analysts on Ironwood Pharmaceuticals, Inc..

What analysts predicted

-51.58%DOWNSIDE

Target Price

$0.95

Current Price

$1.44

Analyzed by

12 Analysts

Target

$0.95

Ironwood Pharmaceuticals, Inc. target price $0.95, a slight downside of -51.58% compared to current price of $1.44. According to 12 analysts rating.

Ironwood Pharmaceuticals, Inc. Stock’s Investor Sentiment and Interest

Search interest for Ironwood Pharmaceuticals, Inc. Stock has increased by 147% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 18, 2025 to October 18, 2025

Change:147% versus previous 30 day period

Ironwood Pharmaceuticals, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	104	107	113	117	74	94	91	90	41	85
Gross Profit	103	107	113	117	74	93	61	90	40	84
Operating Income	60	-1,083	40	37	11	24	25	31	-29	45
EBITDA	67	-1,074	42	39	12	26	27	33	-27	46
Interest Expense	1	1	9	8	7	7	9	8	8	8
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	65	-1,076	31	30	4	18	17	23	-36	37
Income Tax Expense	20	13	17	32	9	19	13	21	1	14
Net Income	45	-1,062	15	-1	-4	0	3	2	-37	23
Net Profit Margin	43.93%	-989.17%	13.47%	-0.92%	-5.56%	-0.91%	3.98%	2.49%	-90.87%	27.69%

Ironwood Pharmaceuticals, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	149	273	298	346	428	389	413	410	442	351
Gross Profit	149	272	278	313	404	298	412	409	442	343
Operating Income	-102	-51	-77	-238	120	142	232	250	-945	93
EBITDA	-99	-31	-33	-144	101	141	233	261	-924	100
Interest Expense	31	39	36	37	36	29	31	7	21	33
Depreciation	-	-	14	14	5	3	1	1	1	2
Income Before Tax	-142	-81	-116	-282	58	108	200	252	-948	65
Income Tax Expense	19	37	34	-5	74	2	-327	77	83	64
Net Income	-142	-81	-116	-282	21	106	528	175	-1,002	0
Net Profit Margin	-95.40%	-29.83%	-39.20%	-81.46%	5.02%	27.26%	127.72%	42.64%	-226.37%	0.25%

Ironwood Pharmaceuticals, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-1,089	13	-1	-4	0	3	2	-37	23
Operating Cash Flow	34	32	35	44	33	9	15	19	-15
Investing Cash Flow	-999	-22	-4	0	0	0	0	0	0
Financing Cash Flow	399	-74	-50	-15	-49	-27	-14	0	0
Change in Cash	-565	-65	-19	29	-16	-17	0	19	-15

Ironwood Pharmaceuticals, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-81	-116	-282	21	106	528	175	-1,002	0
Operating Cash Flow	-25	-99	-70	10	168	261	273	183	103
Investing Cash Flow	-177	151	88	-11	-1	0	0	-1,026	0
Financing Cash Flow	-4	19	30	-1	18	-4	-237	277	-106
Change in Cash	-207	71	48	-1	185	257	36	-565	-3

Global Institutional Holdings in Ironwood Pharmaceuticals, Inc.

Funds	Holdings
Vanguard Group Inc	9.97%
Armistice Capital, LLC	9.94%
Sarissa Capital Management LP	9.8%
BlackRock Inc	7.4%
Renaissance Technologies Corp	5.18%

See all

Insights on Ironwood Pharmaceuticals, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, IRWD stock has moved up by 96.0%
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -37.38M → 23.59M (in $), with an average increase of 258.4% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 41.14M → 85.23M (in $), with an average increase of 51.7% per quarter
NO EFFECT
Against Peers
In the last 1 year, Neurocrine Biosciences Inc. has given 16.1% return, outperforming this stock by 81.2%
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 23.8% return, outperforming this stock by 108.6%

About Ironwood Pharmaceuticals, Inc.

ironwood pharmaceuticals (nasdaq: irwd) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our passionate team to keep doing these two things again and again as we continue to build a leading gastrointestinal therapeutics company. we discovered, developed and are commercializing a medicine for the treatment of adults suffering from irritable bowel syndrome with constipation (ibs-c) or chronic idiopathic constipation (cic). we are also developing a rich pipeline of programs seeking to address patient needs across the upper and lower gastrointestinal tract. our pipeline priorities include exploring further opportunities for our lead medicine, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to advance multiple investigational medicines. ironwood was founded in 1998 out of the whitehead institute for b

Organisation	Ironwood Pharmaceuticals, Inc.
Headquarters	100 Summer Street, Boston, MA, United States, 02110
Industry	Health Technology
CEO	Mr. Thomas A. McCourt
E-voting on shares	Click here to vote

Key Management of Ironwood Pharmaceuticals, Inc.

Name	Title
Mr. Thomas A. McCourt	CEO & Director
Mr. John Minardo	Senior VP, Chief Legal Officer & Secretary
Dr. Michael Shetzline M.D., Ph.D.	Chief Medical Officer, Senior VP and Head of Research & Drug Development
Mr. Gregory Martini	Senior VP, CFO & Investor Relations
Mr. Ronald Silver	Senior VP, Corporate Controller & Principal Accounting Officer
Dr. Rosario Lobrutto M.B.A., M.S., Ph.D.	VP & Global Head of Technical Operations
Ms. Tammi Gaskins	Senior Vice President & Chief Commercial Officer.
Mr. Jeff Ruberti	Chief Strategy Officer

FAQs

What is Ironwood Pharmaceuticals, Inc. share price today?

Ironwood Pharmaceuticals, Inc. share price today is $1.44 as on October 18, 2025 at 1:29 am IST at the close of the market. Ironwood Pharmaceuticals, Inc. share today touched a day high of $1.57 and a low of $1.43.

What is the 52 week high and 52 week low for Ironwood Pharmaceuticals, Inc. share?

Ironwood Pharmaceuticals, Inc. share touched a 52 week high of $5.13 on December 20, 2024 and a 52 week low of $0.53 on May 16, 2025. Ironwood Pharmaceuticals, Inc. stock price today i.e. October 18, 2025 at 1:29 am IST is closed at $1.44,which is 71.92% down from its 52 week high and 173.19% up from its 52 week low.

What is Ironwood Pharmaceuticals, Inc.'s market capitalisation today?

Ironwood Pharmaceuticals, Inc. market capitalisation is $0.00T as on October 18, 2025 at 1:29 am IST.

How to invest in Ironwood Pharmaceuticals, Inc. Stock (IRWD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ironwood Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ironwood Pharmaceuticals, Inc. Shares that will get you 1.0417 shares as per Ironwood Pharmaceuticals, Inc. share price of $1.44 per share as on October 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Ironwood Pharmaceuticals, Inc. Stock (IRWD) from India?

Indian investors can start investing in Ironwood Pharmaceuticals, Inc. (IRWD) shares with as little as ₹88.054 or $1 (as of October 18, 2025 at 5:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.54 in Ironwood Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on October 18, 2025 at 5:38 am IST). Based on Ironwood Pharmaceuticals, Inc. share’s latest price of $1.44 as on October 18, 2025 at 1:29 am IST, you will get 6.9444 shares of Ironwood Pharmaceuticals, Inc.. Learn more about fractional shares .

What are the returns that Ironwood Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?

Ironwood Pharmaceuticals, Inc. stock has given -85.05% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?